Fielmann (FRA:FIE) has been given a €70.00 ($81.40) price objective by equities researchers at HSBC in a research note issued to investors on Friday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. HSBC’s target price would suggest a potential upside of 13.82% from the stock’s previous close.
Other equities research analysts also recently issued research reports about the company. Hauck & Aufhaeuser set a €41.00 ($47.67) price objective on Fielmann and gave the stock a “sell” rating in a research report on Friday, July 12th. Berenberg Bank set a €57.00 ($66.28) price objective on Fielmann and gave the stock a “neutral” rating in a research report on Wednesday, May 22nd. DZ Bank reiterated a “sell” rating on shares of Fielmann in a research report on Friday, July 12th. Independent Research set a €72.00 ($83.72) price objective on Fielmann and gave the stock a “neutral” rating in a research report on Thursday, July 11th. Finally, Kepler Capital Markets set a €50.50 ($58.72) price objective on Fielmann and gave the stock a “sell” rating in a research report on Monday, April 29th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of €60.41 ($70.24).
Shares of FIE stock opened at €61.50 ($71.51) on Friday. Fielmann has a 52-week low of €65.50 ($76.16) and a 52-week high of €77.50 ($90.12). The business’s fifty day moving average is €63.69 and its 200 day moving average is €61.71.
Fielmann Aktiengesellschaft invests in and operates optical and hearing aid businesses in Germany, Switzerland, Austria, and internationally. The company designs, manufactures, distributes, and retails visual aids and other optical products, including glasses, frames, lenses, sunglasses, contact lenses, and related articles and accessories, as well as hearing aids and accessories.
Recommended Story: Portfolio Manager
Receive News & Ratings for Fielmann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fielmann and related companies with MarketBeat.com's FREE daily email newsletter.